DLHAX — Nomura Healthcare Fund
Data updated: 2026-06-12
DLHAX — Nomura Healthcare Fund data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $664.98M AUM · 1.21% expense ratio · 17.4% 1-yr return. From SEC regulatory filings.
DLHAX Fund Overview
DLHAX — Nomura Healthcare Fund is a US mutual fund managed by Delaware Group Equity Funds IV, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Delaware Group Equity Funds IV
- Category: United States Health Care Equity
- Assets under management: $664.98M
- 1-year return: 17.4%
- Ticker: DLHAX
- SEC CIK: 0000778108
- SEC series ID: S000018873
- Share class ID: C000052257
DLHAX Holdings
Top 10 holdings of Nomura Healthcare Fund by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Ucb SA | 5.90% |
| Regeneron Pharmaceuticals, Inc. | 5.46% |
| Pfizer Inc. | 4.83% |
| Gilead Sciences Inc. | 4.40% |
| AbbVie Inc. | 4.09% |
| Merck & Co., Inc | 3.89% |
| AstraZeneca PLC | 3.86% |
| Chugai Pharmaceutical Co Ltd. | 3.73% |
| Eli Lilly & Co. | 3.60% |
| Roche Holding AG | 3.30% |
DLHAX Portfolio Allocation
Asset-class allocation of Nomura Healthcare Fund by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 96.6% |
| Cash & Equivalents | 3.2% |
DLHAX Performance
Total returns for DLHAX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -3.0% |
| 1 year | 17.4% |
| 3 years (annualised) | 11.5% |
| 5 years (annualised) | 7.1% |
DLHAX Risk Information
Risk metrics for DLHAX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 15.3%
DLHAX Costs and Fees
DLHAX costs about $121 per $10,000 invested per year in fund expenses.
- Net expense ratio: 1.21%
- Gross expense ratio: 1.26%
- Portfolio turnover: 5%
- Brokerage commissions: 1.16 bps of average net assets (SEC N-CEN)
DLHAX Cashflows
Over the 12 months to 2026-03, Nomura Healthcare Fund had net outflows of $71.99M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-03 | −$793.60K |
| 2026-02 | $1.79M |
| 2026-01 | −$9.77M |
| 2025-12 | $43.75M |
| 2025-11 | −$6.22M |
| 2025-10 | −$11.74M |
DLHAX Debt Constituents
No individual debt constituents are reported in Nomura Healthcare Fund's latest SEC N-PORT filing.
DLHAX Prospectus and SEC Filings
Official Nomura Healthcare Fund filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.